Diagnostik und Therapie des Hepatozellulären Karzinoms und biliärer Karzinome - Living Guideline. S3-LL (Leitlinienprogramm Onkologie der AWMF, DKG und DKH)
- MeSH Terms
Carcinoma; Hepatocellular (C06.552.697.160); Carcinoma; Hepatocellular (C06.301.623.160); Carcinoma; Hepatocellular (C04.588.274.623.160); Carcinoma; Hepatocellular (C04.557.470.200.025.255)
- Guideline Contact
- Ina Kopp ([email protected])
- English Title Translation
- Diagnosis and therapy of hepatocellular carcinoma and biliary carcinoma
- Keywords
- Krebs, Karzinom, karzinomatös, Tumor, Diagnostik, Therapie, Epidemiologie, Klassifizierung, S3-Leitlinie, Definition, Malignom, Onkologie, Leitlinie, Leitlinienprogramm Onkologie, Deutsche Krebsgesellschaft, DKG, Qualitätsindikator, Hepatozelluläres Karzinom, HCC, biliäre Tumoren, Gallengänge, Gallenblase, Gallenblasenkrebs, Cholangiokarzinom, cholangiozelluläres Karzinom,Leberzellkrebs, Leberzelltumor, Leberzellkarzinom, cancer, carcinoma, cancerous, carcinomatous, tumor, diagnosis, therapy, epidemiology, classification, S3-guideline, definition, malignancy, oncology, guideline, German Guideline Programm in Oncology, GGPO, German Cancer Society, quality indicator, hepatocellular carcinoma, HCC, liver cancer, liver tumor, liver carcinoma, cholangiocarcinoma, bile duct cancer, biliary tract
- Date for Review
- 31/01/2025
- Publication Date
- 05/09/2024
- Publication Scope
- management
- Countries of Application
- Germany
- Guideline Publication Status
- Living guideline
- Languages
- German
- Authors
- AWMF (DE)
- DKG (DE)
- Publication Year
- 2023